New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

The U.S. Supreme Court's 2024 ruling in the Purdue Pharma bankruptcy cases generally prohibiting nonconsensual releases of non-debtors in chapter ...

U.S. District Judge Laura Taylor Swain ruled on Tuesday that the bondholders weren’t entitled to any recovery from Puerto Rico on their debt bonds, as their claims arose from the “purchase or sale of ...

Provisions in chapter 11 plans releasing non-debtors from liability for pre-bankruptcy conduct in exchange for funding for plan distributions ...

Arkansas Attorney General Tim Griffin announced that the state has received $44.5 million as part of a Purdue Pharma settlement.

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

Nebraska could see as much as $19.7 million from the settlement if it moves forward, according to Attorney General Mike Hilger's office.

A new $7.4 billion opioid settlement for Purdue Pharma and the Sackler family has been approved by all U.S. states and territories ...

Purdue Pharma received approval for the company's disclosure statement tied to its chapter 11 reorganization plan that aims to deliver more than $7.4 billion in cash to creditors to compensate ...

Oxycontin maker Purdue Pharma received court approval on Friday to begin voting on its $7.4 billion bankruptcy settlement, while deferring questions about how state and local governments should ...

A judge has advanced OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids. State governments across the country have already signed on to ...

OxyContin maker Purdue Pharma ‘s $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids will be sent to local governments, people who became addicted to the drug and ot… ...